Why GLP-1?

Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Trusted brands in one place

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
High-Dose Wegovy: Up to 28% Weight Loss
GLP-1 Agonists

High-Dose Wegovy: Up to 28% Weight Loss

Novo Nordisk has reported that a higher-dose formulation of Wegovy (semaglutide) helped certain patients lose nearly 28% of their body weight. This is a meaningful jump from the results seen with the current standard dose. Here's what patients and prospective users should know before their next doctor's visit.

Read More
Medicare Coverage for GLP-1 Weight-Loss Drugs
GLP-1 Agonists

Medicare Coverage for GLP-1 Weight-Loss Drugs

A new Medicare program could dramatically lower the cost of GLP-1 weight-loss medications for millions of eligible Americans. Here's what the coverage changes mean for your wallet, your provider options, and how to take advantage of expanded access.

Read More
Higher-Dose Wegovy: 28% Weight Loss Results
Weight Loss

Higher-Dose Wegovy: 28% Weight Loss Results

Novo Nordisk has reported that a higher-dose formulation of Wegovy (semaglutide) achieved roughly 28% weight loss in early responders. This could reshape how doctors approach dosing for patients who respond well early in treatment. Here's what the data means for you and questions worth asking your provider.

Read More
Medicare GLP-1 Drugs: $50 Cap Coming This Summer
News & Updates

Medicare GLP-1 Drugs: $50 Cap Coming This Summer

A major cost shift is coming for some Medicare enrollees this summer, with GLP-1 medications dropping to a $50 cap. This article breaks down who qualifies, which drugs are included, and what steps to take now to prepare.

Read More
Ozempic Wrongful Death Lawsuits: What Patients Need to Know
News & Updates

Ozempic Wrongful Death Lawsuits: What Patients Need to Know

A wrongful death lawsuit filed against Ozempic's maker is drawing attention to GLP-1 medication risks and patient safety. If you're currently taking or considering a GLP-1 drug, here's what the growing litigation wave means for you, and what questions to ask your doctor before your next dose.

Read More
GLP-1 Shots vs. Pills: Which Is Right for You?
Drug Comparisons

GLP-1 Shots vs. Pills: Which Is Right for You?

GLP-1 medications now come in both injectable and pill form, giving patients more choices than ever. But more options can mean more confusion. This guide breaks down the real differences in weight loss results, convenience, cost, and side effects so you can have a smarter conversation with your doctor.

Read More
Can GLP-1 Drugs Mask Cancer Symptoms?
News & Updates

Can GLP-1 Drugs Mask Cancer Symptoms?

Some patients taking GLP-1 medications like Ozempic and Mounjaro report that side effects masked early cancer warning signs, delaying diagnosis. This article breaks down which symptoms overlap, what the research says, and how to protect yourself while staying on track with your weight loss goals.

Read More
Generic Ozempic: What It Means for Your Costs
News & Updates

Generic Ozempic: What It Means for Your Costs

Generic versions of semaglutide (the drug in Ozempic) are entering the conversation in a big way. Real patients who've seen dramatic results are cheering the shift. Here's what the arrival of generics could mean for your wallet and your access to treatment.

Read More
Ozempic for Weight Loss After 65: What the Research Shows
News & Updates

Ozempic for Weight Loss After 65: What the Research Shows

A new study finds that Ozempic produces meaningful weight loss in adults over 65, a group often left out of major clinical trials. Here is what older adults and their families should know about semaglutide's effectiveness, safety considerations, and practical next steps for getting started.

Read More